Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain - PubMed (original) (raw)

Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain

S Omura et al. Antimicrob Agents Chemother. 1986 Jan.

Abstract

Hybrid antibiotics mederrhodins A and B were produced by a recombinant strain consisting of the medermycin-producing Streptomyces sp. strain AM7161 containing part of the gene clusters for actinorhodin biosynthesis of Streptomyces coelicolor A3(2). Mederrhodin A has a hydroxyl group at the C-6 position of the medermycin molecule, and mederrhodin B is dihydromederrhodin A. The antimicrobial activity of mederrhodin A resembled that of medermycin. Mederrhodin B was almost devoid of antimicrobial activity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1969 May;63(1):198-204 - PubMed
    1. Gene. 1985;35(3):223-35 - PubMed
    1. J Antibiot (Tokyo). 1978 Oct;31(10):959-65 - PubMed
    1. Z Allg Mikrobiol. 1980;20(8):527-30 - PubMed
    1. J Antibiot (Tokyo). 1980 Dec;33(12):1570-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources